Epsilon M&A Deal Report - Actavis Generics Commercial Operations In Euro Zone Markets
Transaction Multiples for the Valuation of Private Companies
Aurobindo Pharma / Actavis Generics Commercial Operations In Euro Zone Markets
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ![]() |
![]() |
ns | ![]() |
||||
Current | ![]() |
![]() |
Multiple available |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
Date | Acquirer | Target | Country | Multiples | See details |
19/05/2011 | STADA Arzneimittel | Spirig Healthcare | Switzerland | ** | 62850 |
03/02/2014 | Private Group led by IDI | Winncare | France | * | 62374 |
Source: Epsilon Research / EMAT